 |
|---|
We aim to make cervical screening more acceptable and accessible to women.
Program ROSE uses a revolutionary approach to cervical screening by:
Featuring self-sampling by women themselves, instead of pelvic examination by healthcare professionals.
HPV testing, instead of a pap smear diagnostic test for abnormal cells.
Use of secure digital e-health platform that allows women to have all their follow up communicated through their mobile phone.
Program ROSE was specifically designed for Malaysian women.
This evidence based approach can save lives and spare women and families from the suffering and financial hardship associated with cervical cancer.
ROSE AT A GLANCE
ROSE FOUNDATION was established in 2019 as a company limited by guarantee and as a charitable foundation in Malaysia. It is a joint venture between the University of Malaya and VCS Foundation (VCS, formerly the Victorian Cytology Service Inc.), Australia. ROSE Foundation also runs the ROSE Laboratory to provide a centralized cervical screening service using HPV testing.
ROSE Foundation has set itself the ambitious goal of making Malaysia one of the first nations in the region to be free of cervical cancer. To achieve this, the Foundation’s Program ROSE (Removing Obstacles to cervical ScrEening) was launched on 14 January 2019 by the Deputy Prime Minister and Minister of Women, Family and Community Development, Dato’ Seri Dr Wan Azizah Wan Ismail. Both the Ministry of Women, Family and Community Development and the Ministry of Health are also moving towards eliminating cervical cancer in Malaysia, and Program ROSE is playing a pivotal role in accelerating the process.
Program ROSE started off as Pilot Project ROSE, a research project led by University of Malaya. The aim of this pilot project was to assess the acceptability, feasibility and reach of a novel cervical screening strategy that utilized self-sampling in primary care settings, HPV (Human Papillomavirus) testing and follow-up of screened positive women in a tertiary hospital in Malaysia.
Instead of the conventional pap smear conducted by a healthcare professional, involving a pelvic examination, Program ROSE offers women the choice of using a self-swab: a quick, convenient and effective approach to enable molecular tests to be undertaken followed by prompt delivery of results straight to women's mobile phone.
UPCOMING EVENTS
In conjunction with World Health Day, themed ‘Building a Fairer and Healthier world’, ROSE Foundation and Etiqa are pleased to invite you to an event to celebrate the success of Etiqa's 'Free Cervical Screening Program’.
Date: Tuesday, 6th April 2021
Time: 2.30 - 4:00pm
Link to Live Stream event: https://www.facebook.com/ProgramROSE
A forum titled ‘Frontliners Uniting Against Cervical Cancer’ featuring key speakers will follow the launch.
ANNOUNCEMENTS
[Kuala Lumpur, 18 November 2020] ROSE Foundation is very pleased to announce that it has recently been awarded a Merck Sharp & Dohme (MSD) International Neighbour of Choice (INOC) grant. The INOC grant is MSD’s charitable program designed to support outstanding work by non-profit organizations whose mission is to improve the quality of life of people and the environment in communities
ROSE FOUNDATION was established in 2019 as a company limited by guarantee and as a charitable foundation in Malaysia. It is a joint venture between the University of Malaya and VCS Foundation (VCS, formerly the Victorian Cytology Service Inc.), Australia. ROSE Foundation also runs the ROSE Laboratory to provide a centralized cervical screening service using HPV testing. It executes Program ROSE as an innovative cervical screening strategy developed in Malaysia in collaboration with VCS Foundation using the principles of design thinking. It focuses on making cervical cancer screening more acceptable and accessible to Malaysian women.
The program encourages women of eligible age to perform self-sampling, a process where women use a Copan Floqswab to collect their own sample from the vagina (not cervix) thus replacing the conventional Pap smear with HPV (Human Papillomavirus) DNA testing. In addition, by incorporating a secure digital e-health platform, women are empowered to register and have all their follow ups communicated via a mobile phone.
Since the launch of ROSE Foundation in July 2019, over 7000 women have benefited from the program and recently, more parties have begun to express their interest to contribute to the Foundation’s cause. Hence, winning this grant opened the door to new opportunities and enabled the Foundation to move a step closer towards achieving its ambition.
As the world focuses on the COVID-19 pandemic and re-prioritising health care resources from non-communicable diseases to communicable disease, it is time for the health care system to transform and adopt new practices to improve health outcomes. Self-care interventions is a powerful tool for women empowerment and frontliners play a crucial role in the execution of this practice. According to the World Health Organization (WHO), the scope of self-care interventions includes health promotion and disease prevention. It is a promising approach in placing women at the centre of healthcare, at the same time ensuring the accountability of the health care system.
Therefore, ROSE Foundation came up with a campaign targeting the frontliners in Malaysia as we believe that they are the key personnel to accelerate the integration of self care for sexual and reproductive health rights (SRHR), with an emphasis on cervical cancer prevention. This is with the aim of frontliners taking charge of their own SRHR and ultimately sensitizing the community they interact with on SRHR.
“We want all women in Malaysia to know about cervical cancer and to know it’s preventable. They must be informed about how this cancer can be prevented and where to go for help. We want our community to be knowledgeable and support girls and women in prevention initiatives including vaccination and screening programs to prevent cervical cancer,” said Prof. Adeeba Kamarulzaman, the chair of ROSE Foundation.
The grant will be used to enhance the public awareness on cervical cancer through various physical and digital platforms in the hope that more women are well-informed of Program ROSE and eventually benefit from it.